Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 1/2012

01.09.2012 | Case Report

Dermatitis Herpetiformis: Rare Cutaneous Manifestation of Colon Adenocarcinoma

verfasst von: Justin Hartke, Julian Trevino, Salma Akram

Erschienen in: Journal of Gastrointestinal Cancer | Sonderheft 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

A previously healthy mildly obese 72-year-old Caucasian male with well-controlled type II diabetes presented with a 2-month history of a pruritic papulovesicular rash on the extensor surface of the forearms. Skin punch biopsy showed subepidermal multilocular bullous lesions with edema and neutrophils (Fig. 1). Direct immunofluorescence showed dense granular deposits of IgA in the basement membrane and at the tips of dermal papillae, consistent with the diagnosis of dermatitis herpetiformis (DH) (Fig. 2). The patient did not have any gastrointestinal symptoms, and celiac disease serology including anti-endomysial antibodies and anti-tissue transglutaminase IgA and IgG were negative. The patient did not have any significant improvement in skin lesions on dapsone and gluten-free diet. Six months later, the patient presented with acute onset of right-sided abdominal pain, generalized weakness, anorexia, 25-lb weight loss, and several episodes of melena with iron deficiency anemia. A CT scan of the abdomen showed focal colonic wall thickening and a 5.5-cm hepatic flexure pericolonic fluid collection containing air, which was suggestive of focal perforation with a pericolonic abscess. Multiple enhancing liver lesions were noted which were suspicious for metastatic disease. Lymphadenopathy was noted in the right upper abdomen, involving the portacaval, periportal, and celiac axis regions. The largest lymph node, located in the portacaval region, measured up to 3.2 cm. Colonoscopy 3 years prior was normal. Carcinoembryonic antigen level was elevated at 414. Due to risk of perforation, colonoscopy was delayed pending image-guided biopsy. Biopsy of the liver lesions revealed poorly differentiated adenocarcinoma. Subsequent colonoscopy showed a 9-cm friable, ulcerated, partially obstructing mass extending from the hepatic flexure to the proximal transverse colon (Fig. 3). Endoscopic mucosal biopsies were consistent with poorly differentiated adenocarcinoma. Immunohistochemistry was positive for CK7, mucin, and CK20 and negative for CDX2, TTF-1, chromogranin, synaptophysin, PSA, and PAP. The patient's clinical condition deteriorated rapidly, and he passed away 1 month following the diagnosis of metastatic colon cancer.
Literatur
1.
Zurück zum Zitat Fry L. Dermatitis herpetiformis: problems, progress and prospects. Eur J Dermatol. 2002;12:523–31.PubMed Fry L. Dermatitis herpetiformis: problems, progress and prospects. Eur J Dermatol. 2002;12:523–31.PubMed
2.
Zurück zum Zitat Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol. 2011;64:1017–24.PubMedCrossRef Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol. 2011;64:1017–24.PubMedCrossRef
3.
Zurück zum Zitat Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol. 1996;132:912–8.PubMedCrossRef Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol. 1996;132:912–8.PubMedCrossRef
4.
Zurück zum Zitat Salmi TT, Hervonen K, Kautiainen H, et al. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol. 2011;165:354–9.PubMedCrossRef Salmi TT, Hervonen K, Kautiainen H, et al. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol. 2011;165:354–9.PubMedCrossRef
5.
Zurück zum Zitat Antiga E, Caproni M, Pierini I, et al. Gluten-free diet in patients with dermatitis herpetiformis: not only a matter of skin. Arch Dermatol. 2011;147:988–9.PubMedCrossRef Antiga E, Caproni M, Pierini I, et al. Gluten-free diet in patients with dermatitis herpetiformis: not only a matter of skin. Arch Dermatol. 2011;147:988–9.PubMedCrossRef
6.
Zurück zum Zitat Leonard JN, Tucker WF, Fry JS, et al. Increased incidence of malignancy in dermatitis herpetiformis. Br Med J (Clin Res Ed). 1983;286:16–8.CrossRef Leonard JN, Tucker WF, Fry JS, et al. Increased incidence of malignancy in dermatitis herpetiformis. Br Med J (Clin Res Ed). 1983;286:16–8.CrossRef
7.
Zurück zum Zitat Reunala TL, Leonard JN. Malignant disease in dermatitis herpetiformis. Clin in Derm. 1992;9:369–73.CrossRef Reunala TL, Leonard JN. Malignant disease in dermatitis herpetiformis. Clin in Derm. 1992;9:369–73.CrossRef
8.
Zurück zum Zitat Swerdlow AJ, Whittaker S, Carpenter LM, et al. Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study. Br J Dermatol. 1993;129:140–4.PubMedCrossRef Swerdlow AJ, Whittaker S, Carpenter LM, et al. Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study. Br J Dermatol. 1993;129:140–4.PubMedCrossRef
9.
Zurück zum Zitat Collin P, Pukkala E, Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with celiac disease. Gut. 1996;38:528–30.PubMedCrossRef Collin P, Pukkala E, Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with celiac disease. Gut. 1996;38:528–30.PubMedCrossRef
10.
Zurück zum Zitat Askling J, Linet M, Gridley G, et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123:1428–35.PubMedCrossRef Askling J, Linet M, Gridley G, et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123:1428–35.PubMedCrossRef
11.
Zurück zum Zitat Viljamaa M, Kaukinen K, Pukkala E, et al. Malignancies and mortality in patients with celiac disease and dermatitis herpetiformis: 30-year population based study. Dig Liver Dis. 2006;38:374–80.PubMedCrossRef Viljamaa M, Kaukinen K, Pukkala E, et al. Malignancies and mortality in patients with celiac disease and dermatitis herpetiformis: 30-year population based study. Dig Liver Dis. 2006;38:374–80.PubMedCrossRef
12.
Zurück zum Zitat Alonso-LLamazares J, Gibson LE, Rogers RS. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. Internat J Derm. 2007;46:910–9.CrossRef Alonso-LLamazares J, Gibson LE, Rogers RS. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. Internat J Derm. 2007;46:910–9.CrossRef
13.
Zurück zum Zitat Lewis HM, Reunala TL, Garioch JJ, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996;135:363–7.PubMedCrossRef Lewis HM, Reunala TL, Garioch JJ, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996;135:363–7.PubMedCrossRef
14.
Zurück zum Zitat Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005;128:S79–86.PubMedCrossRef Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005;128:S79–86.PubMedCrossRef
15.
Zurück zum Zitat Hervonen K, Vornanen M, Kautiainen H, Collin P, Reunala T. Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol. 2005;152:82–6.PubMedCrossRef Hervonen K, Vornanen M, Kautiainen H, Collin P, Reunala T. Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol. 2005;152:82–6.PubMedCrossRef
16.
Zurück zum Zitat Sigurgeirsson B, Agnarsson BA, Lindelof B. Risk of lymphoma in patients with dermatitis herpetiformis. Br Med J. 1994;308:13–5.CrossRef Sigurgeirsson B, Agnarsson BA, Lindelof B. Risk of lymphoma in patients with dermatitis herpetiformis. Br Med J. 1994;308:13–5.CrossRef
17.
Zurück zum Zitat Bickle K, Roark TR, Hsu S. Autoimmune bullous dermatoses: a review. Am Fam Physician. 2002;65:1861–70.PubMed Bickle K, Roark TR, Hsu S. Autoimmune bullous dermatoses: a review. Am Fam Physician. 2002;65:1861–70.PubMed
Metadaten
Titel
Dermatitis Herpetiformis: Rare Cutaneous Manifestation of Colon Adenocarcinoma
verfasst von
Justin Hartke
Julian Trevino
Salma Akram
Publikationsdatum
01.09.2012
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe Sonderheft 1/2012
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-012-9381-6

Weitere Artikel der Sonderheft 1/2012

Journal of Gastrointestinal Cancer 1/2012 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.